Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIO Digital: Investment Panel Sees Continued Rising Adoption Of Telehealth, Remote Monitoring

Executive Summary

BIO Digital investment panel sees strong investment opportunities in telehealth, remote monitoring and converging digital products.

You may also be interested in...



FDA Approves Abbott’s Pain Management Controller App

The smartphone-compatible app works with Abbott’s implantable neuromodulation technologies as part of its NeuroSphere Digital Care connected care management platform.

Rock Health Reports Record Digital Health Funding Of $5.4Bn In H1 2020, Sees Potential For Record-Year Funding

Digital health funding is on track for the largest funding year ever amid the COVID-driven demand for telehealth and remote monitoring of patients. However, a large second wave of the pandemic could reverse that trend.

COVID-19 Telehealth-Use Explosion Gets US Senators Crossing Party Lines To Expand Its Practice

Many US senators became telemedicine converts during this spring’s COVID-19 trial-by-fire use of the health care delivery option, and avidly pushed bills to back it at a mid-June hearing.

Related Content

Topics

UsernamePublicRestriction

Register

MT142283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel